Tuberculosis in times of COVID-19: Challenges and opportunities

This study discusses how the endTB project, which had the aim to eradicate tuberculosis by 2030, has been affected by addressing emerging pathologies; consequently, an increase in the rate of infection and mortality by tuberculosis was reported in 2021. Although the scientific community focuses on COVID-19, we cannot forget tuberculosis. Both pathologies show important similarities, which suggest that investment in research in both study fields can be used to develop new diagnostic and therapeutic strategies for both pathologies. The analysis of tuberculosis, an infectious disease that is a public health problem worldwide, under the COVID-19 context is helpful to highlight the shortcomings of health systems worldwide.